We are live on ! Find out more
KFO

Kopp Family Office Portfolio holdings

AUM $163M
1-Year Est. Return 22.57%
This Fund
S&P 500
This Quarter Est. Return
+48.44%
1 Year Est. Return
+22.57%
3 Year Est. Return
+33.98%
5 Year Est. Return
+1.93%
10 Year Est. Return
–
AUM
$157M
AUM Growth
–
Cap. Flow
+$129M
Cap. Flow %
81.99%
Top 10 Hldgs %
100%
Holding
5
New
5
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
NEO icon
NeoGenomics
NEO
+$115M
2
SRGA
Surgalign Holdings, Inc. Common Stock
SRGA
+$8.67M
3
FIVN icon
FIVE9
FIVN
+$1.75M
4
VCEL icon
Vericel Corp
VCEL
+$1.7M
5
XENT
Intersect ENT, Inc
XENT
+$1.52M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 97.62%
2 Technology 1.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NEO icon
1
NeoGenomics
NEO
$1.96B
$142M 90.06%
+4,844,625
New +$115M
SRGA
2
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
$10.2M 6.46%
+123,661
New +$8.67M
FIVN icon
3
FIVE9
FIVN
$2.11B
$1.87M 1.19%
+28,550
New +$1.75M
XENT
4
DELISTED
Intersect ENT, Inc
XENT
$1.87M 1.19%
+75,000
New +$1.52M
VCEL icon
5
Vericel Corp
VCEL
$2.35B
$1.74M 1.1%
+99,800
New +$1.7M

Similar funds

OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
PCR
Potrero Capital Research San Francisco, California $163M AUM 79.07% 1-Year Est. Return
TCGDR
TB Capital Gestao de Recursos Rio De Janeiro $163M AUM 20.86% 1-Year Est. Return
IPWA
International Private Wealth Advisors San Diego, California $163M AUM 16.99% 1-Year Est. Return
IVGAI
Index Venture Growth Associates IV St. Helier, Jersey $163M AUM 54.88% 1-Year Est. Return
CC
Cannell Capital Alta, Wyoming $163M AUM 40.62% 1-Year Est. Return
GP
Gridiron Partners Wexford, Pennsylvania $164M AUM 3.31% 1-Year Est. Return
PWAM
Papamarkou Wellner Asset Management New York $164M AUM 25.23% 1-Year Est. Return

Kopp Family Office's Q4 2019 Portfolio in Review

Q4 2019 is the first quarter with a 13F filing on record for Kopp Family Office, which disclosed 5 positions worth $157M. Its ten largest holdings account for 100% of the portfolio.

Its largest position is NeoGenomics: 4,844,625 shares worth $142M.

By sector, the portfolio is most concentrated in Healthcare at 98% of assets, followed by Technology.

  • Kopp Family Office's largest Q4 2019 buy was NeoGenomics: 4,844,625 shares worth $142M.
  • Kopp Family Office's ten largest holdings make up 100% of its $157M portfolio in Q4 2019.
  • Kopp Family Office disclosed 5 positions in Q4 2019, its first 13F filing on record.

Based on Kopp Family Office's 13F filing for Q4 2019, filed 14 Feb 2020.